Furthermore, they suggest that cortical excitability could constitute a specific biomarker of early misfolded tau protein aggregates and neuroinflammation in the brainstem and, potentially, of increased risk for AD in cognitively normal healthy individuals. The gene discussed is MAPT; the disease is Alzheimer disease.